» Articles » PMID: 11559519

Potential Value of Vertebral Proton MR Spectroscopy in Determining Bone Weakness

Overview
Specialty Neurology
Date 2001 Sep 18
PMID 11559519
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Increased fat content in vertebrae may indicate bone weakness. Vertebral proton MR spectroscopy ((1)H MRS) quantitatively measures vertebral fat relative to water. Thus, (1)H MRS measurements of percent fat fraction (%FF) and spectral line width (LW) of vertebral bone marrow may differ between subjects with and those without MR imaging evidence of weakened bone.

Methods: We measured %FF and LW in 22 subjects with (15 men and 7 women, aged 26 to 80 years) and 72 control subjects without (33 male and 39 female subjects, aged 15 to 87 years) MR findings of weakened bone, including prominent Schmorl's nodes, endplate depression, vertebral wedging, and vertebral compression fractures. In those with bone weakness, (1)H MRS data were sampled from an intact vertebra, usually L2. Data were analyzed for differences by age and sex. We compared the mean %FF and LW in subjects with and in those without bone weakness by use of Student's t test.

Results: The %FF increased linearly with age in the control subjects, ranging from 20.5% in the second and third decades of life to 49.4% in eighth or ninth decades of life. Across all age groups, male control subjects had a higher aggregate %FF than did female control subjects. Male control subjects tended to have a greater LW than did female control subjects, but differences between the sexes within or across age groups were not significant. Contrary to expectations, LW was greatest in the oldest control subjects and lowest among younger control subjects, but there were insufficient data points to make definitive conclusions. Overall, %FF was a relative 45% higher in subjects with weakened bone compared with control subjects (48.8 vs 33.6 [P <.001]). The subjects with evidence of vertebral bone weakness also had a higher overall mean LW (37 vs 29 Hz [P <.002]), but this finding is of uncertain importance.

Conclusion: The %FF was significantly higher within the L2 vertebral body in 22 subjects with weakened bone compared with the control group, suggesting that it could serve as a measure of bone quality. The LW measurements did not yield meaningful conclusions.

Citing Articles

Assessment of Vertebral Bone Marrow Perfusion, Fat/Water Content, and Trabecular Bone Changes Using Multimodal MRI and Micro-CT in a Rat Model of Chronic Kidney Disease.

Huang G, Chiang S, Peng Y, Yeh S, Hsu Y, Chou Y JOR Spine. 2025; 8(1):e70039.

PMID: 39838972 PMC: 11745900. DOI: 10.1002/jsp2.70039.


Preliminary study of proton magnetic resonance spectroscopy to assess bone marrow adiposity in the third metacarpus or metatarsus in Thoroughbred racehorses.

Hewitt-Dedman C, Kershaw L, Schwarz T, Del-Pozo J, Duncan J, Daniel C Equine Vet J. 2024; 57(2):471-479.

PMID: 38699829 PMC: 11807939. DOI: 10.1111/evj.14086.


Myosteatosis and bone marrow adiposity are not associated among postmenopausal women with fragility fractures.

Badr S, Dapvril H, Lombardo D, Khizindar H, Martin C, Cortet B Front Endocrinol (Lausanne). 2023; 14:1178464.

PMID: 37404309 PMC: 10316646. DOI: 10.3389/fendo.2023.1178464.


Advancement in the Treatment of Osteoporosis and the Effects on Bone Healing.

Kushchayeva Y, Pestun I, Kushchayev S, Radzikhovska N, Lewiecki E J Clin Med. 2022; 11(24).

PMID: 36556093 PMC: 9781093. DOI: 10.3390/jcm11247477.


Multiparametric MRI to quantify disease and treatment response in mice with myeloproliferative neoplasms.

Robison T, Solipuram M, Heist K, Amouzandeh G, Lee W, Humphries B JCI Insight. 2022; 7(19).

PMID: 35998053 PMC: 9675444. DOI: 10.1172/jci.insight.161457.


References
1.
Nuttall M, Gimble J . Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?. Bone. 2000; 27(2):177-84. DOI: 10.1016/s8756-3282(00)00317-3. View

2.
Schick F, Einsele H, Bongers H, Jung W, Skalej M, Duda S . Leukemic red bone marrow changes assessed by magnetic resonance imaging and localized 1H spectroscopy. Ann Hematol. 1993; 66(1):3-13. DOI: 10.1007/BF01737683. View

3.
Demmler K, Otte P, Bartl R, Burkhardt R, Frisch B, Jahn A . [Osteopenia, marrow atrophy and capillary circulation. Comparative studies of the human iliac crest and 1st lumbar vertebra]. Z Orthop Ihre Grenzgeb. 1983; 121(3):223-7. DOI: 10.1055/s-2008-1051346. View

4.
Rosen B, Fleming D, Kushner D, Zaner K, Buxton R, Bennet W . Hematologic bone marrow disorders: quantitative chemical shift MR imaging. Radiology. 1988; 169(3):799-804. DOI: 10.1148/radiology.169.3.3187003. View

5.
Riggs B, Wahner H, Melton 3rd L, Richelson L, Judd H, Offord K . Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest. 1986; 77(5):1487-91. PMC: 424550. DOI: 10.1172/JCI112462. View